Judge: Teva not liable for Oxycontin patent violation

Share this article:

Generics and branded drugmaker Teva took a swing and won against painkiller company Purdue Pharma.

Bloomberg reports that Purdue, whose name is synonymous with Oxycontin, lost a legal battle in which it asserted that Teva's generic violated multiple patents.

US District Judge Sidney Stein agreed that Teva overstepped three patents, but said the “obvious” nature of the patents meant he was not going to hold the company liable.

Purdue told Bloomberg it will appeal the decision.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.